Climb Bio, Inc. financial statements
Climb Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 59.85M | 10-K |
| Cash and equivalents | USD 35.69M | 10-Q |
| Total debt | USD 541K | EODHD |